Glenspray – Glenmark Pharmaceuticals

Registered App ID 2889131 Class 5 Word

Trademark information

IP India · live record
Application ID
2889131
Status
Registered
Sub status
—
Date of application
27 January 2015
Classes
5
Type
Word
Proprietor
Glenmark Pharmaceuticals Public B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai 400026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage, Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
Branch Office
IP office
Mumbai
Used since
—
Valid / upto
27 January 2035

Goods & services

Class 5

Class 5MEDICINAL, PHARMACEUTICAL AND AYURVEDIC PREPARATIONS AND SUBSTANCES, DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL USE, DIETARY SUPPLEMENTS FOR HUMANS, NUTRITIONAL SUPPLEMENTS

PR details

GLENMARK PHARMACEUTICALS LTD., B/2, MAHALAXMI CHAMBERS, 22, BHULABHAI DESAI ROAD, MUMBAI-400026, A COMPANY REGISTERED UNDER THE COMPANIES ACT, 1956, MANUFACTURERS AND TRADING MERCHANTS, (Body Incorporate)

REGISTRATION RENEWED FOR A PERIOD OF 10 YEARS FROM 27/01/2025 ADVERTISED IN JOURNAL NO. 2189

Uploaded documents

Sign in to open
1 Power of Attorney 27 Jan 2015
1 TM-1 27 Jan 2015
2 Power of Attorney 27 Jan 2015
2 TM-1 27 Jan 2015
3 Additional Representation Sheet 27 Jan 2015
4 Reply to Exam Report (MIS-R) 09 Feb 2016
5 Journal Copy 20 Jul 2018
6 Certificate 18 Oct 2018
7 TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) 24 Mar 2023
8 TM-R(RENEWAL OF TRADE MARK) 19 Dec 2024

Correspondence and notices

1 Hearing Notice (Show Cause) 6232947 · 2825843 16 Apr 2018
2 Tribunal Accepted Notice for : 2889131 6403662 · 2826635 24 May 2018
3 O3 NOTICE 19044037 · 6967178 23 Oct 2024
4 RENEWAL INTIMATION LETTER 19367536 22 Dec 2024

Frequently asked questions

Glenspray was applied for on 27 January 2015.

The application was filed by Glenmark Pharmaceuticals.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Glenspray is 2889131.

Trademark attorney Vishesh And Associates.